$2.490
+0.126 (+5.06%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BYAH por análisis de gráficos similares
Alphio's BYAH stock price prediction model matches the current Park Ha Biological Technology Co Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.33 (-1.23%). The 1-week path is $2.37 (+0.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Park Ha Biological Technology Co Ltd?
Given the current price of $2.20 and a year-to-date change of -96.77%, BYAH is not a good buy right now. The RSI is at 29.607, indicating that the stock is oversold, but the negative performance trends and high volatility suggest significant risks. The forward P/E is 0, indicating uncertainty about future earnings, and the stock has dropped 98.57% over the past year, which raises serious concerns about its viability.
BYAH cerró en $2.49 el Wednesday, tras subir +5.06%
Park Ha Biological Technology Co Ltd (BYAH) last closed at $2.36, losing -5.22%. These facts feed the 1-day and 1-week BYAH price prediction above.
Factores de la previsión
Los factores de la previsión de Park Ha Biological Technology Co Ltd (BYAH) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BYAH, ordenadas por similitud.
Análisis de estacionalidad de BYAH
Historically the probability of a positive October return for BYAH is 0.00%. January offers the highest probability of a positive month at 5.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.